OrgUnit's Researchers
(Persons)

Results 1-5 of 24 (Search time: 0.002 seconds).

FullnameTranslated NameEmail
Agarwal, RishuRishu.AGARWAL@austin.org.au
Baker, AmyAmy.BAKER@austin.org.au
Bennett, AshwiniAshwini.BENNETT@austin.org.au
Berlangieri, Salvatore USam.Berlangieri@austin.org.au
Chua, Chong Chynchyn.chua2@austin.org.au

OrgUnit's Researchers publications
(Dept/Workgroup Publication)

Results 261-280 of 303 (Search time: 0.012 seconds).

Publication YearTitleAuthor(s)
261Dec-2023Significant heterogeneity in management of calreticulin-mutated essential thrombocythemia and its progression to myelofibrosis: results of a national survey.Murton, Alexandra; Forsyth, Cecily; Ross, David M; Grigg, Andrew P 
262Nov-2021Simplified Geriatric Assessment in Older Patients With Diffuse Large B-Cell Lymphoma: The Prospective Elderly Project of the Fondazione Italiana Linfomi.Merli, Francesco; Luminari, Stefano; Tucci, Alessandra; Arcari, Annalisa; Rigacci, Luigi; Hawkes, Eliza A ; Chiattone, Carlos S; Cavallo, Federica; Cabras, Giuseppina; Alvarez, Isabel; Fabbri, Alberto; Re, Alessandro; Puccini, Benedetta; Barraclough, Allison ; Delamain, Marcia Torresan; Ferrero, Simone; Usai, Sara Veronica; Ferrari, Angela; Cencini, Emanuele; Pennese, Elsa; Zilioli, Vittorio Ruggero; Marino, Dario; Balzarotti, Monica; Cox, Maria Christina; Zanni, Manuela; Di Rocco, Alice; Lleshi, Arben; Botto, Barbara; Hohaus, Stefan; Merli, Michele; Sartori, Roberto; Gini, Guido; Nassi, Luca; Musuraca, Gerardo; Tani, Monica; Bottelli, Chiara; Kovalchuk, Sofia; Re, Francesca; Flenghi, Leonardo; Molinari, Annalia; Tarantini, Giuseppe; Chimienti, Emanuela; Marcheselli, Luigi; Mammi, Caterina; Spina, Michele
263Aug-2020Single-agent activity of phosphatidylinositol 3-kinase inhibition with copanlisib in patients with molecularly defined relapsed or refractory diffuse large B-cell lymphoma.Lenz, Georg; Hawkes, Eliza A ; Verhoef, Gregor; Haioun, Corinne; Thye Lim, Soon; Seog Heo, Dae; Ardeshna, Kirit; Chong, Geoffrey ; Haaber, Jacob; Shi, Wei; Gorbatchevsky, Igor; Lippert, Susanne; Hiemeyer, Florian; Piraino, Paolo; Beckmann, Georg; Peña, Carol; Buvaylo, Viktoriya; Childs, Barrett H; Salles, Gilles
2647-Dec-2023Sorafenib plus intensive chemotherapy in newly diagnosed FLT3-ITD AML:a randomized, placebo-controlled study by the ALLG.Loo, Sun; Roberts, Andrew W; Anstee, Natasha S; Kennedy, Glen A; He, Simon Zhao-Xiong; Schwarer, Anthony P ; Enjeti, Anoop Kumar; D'Rozario, James; Marlton, Paula; Bilmon, Ian; Taper, John M; Cull, Gavin; Tiley, Campbell; Verner, Emma; Hahn, Uwe; Hiwase, Devendra K; Iland, Harry J; Murphy, Nicholas Edward; Ramanathan, Sundra; Reynolds, John; Ong, Doen Ming; Tiong, Ing Soo; Wall, Meaghan; Murray, Michael; Rawling, Tristan; Leadbetter, Joanna; Rowley, Leesa; Latimer, Maya; Yuen, Sam L S; Ting, Stephen B; Fong, Chun Yew ; Morris, Kirk Lachlan; Bajel, Ashish; Seymour, John F; Levis, Mark J; Wei, Andrew H
2651-Jan-2004Splenic infarction mimicking gastric remnant on PET imaging.Ollenberger, Glenn P; Berlangieri, Salvatore U 
266Jun-2021Stereotactic body radiotherapy in the management of hepatocellular carcinoma: An Australian multi-institutional patterns of practice review.Liu, Howard Yu-Hao; Lee, Yoo-Young Dominique; Sridharan, Swetha; Choong, Ee Siang; Le, Hien; Wang, Wei; Khor, Richard ; Chu, Julie; Oar, Andrew; Mott, Rebekah; Smart, Joanne; Jenkins, Trish ; Anderson, Nigel; Cross, Shamira; Loo, Kee Fong; Wigg, Alan; Stuart, Katherine; Pryor, David
721-Feb-2022Stereotactic radiotherapy and the potential role of magnetic resonance-guided adaptive techniques for pancreatic cancer.Ermongkonchai, Tai; Khor, Richard ; Muralidharan, Vijayaragavan ; Tebbutt, Niall C ; Lim, Kelvin K M ; Kutaiba, Numan ; Ng, Sweet Ping 
82019Strategies to enhance the graft versus tumour effect after allogeneic haematopoietic stem cell transplantation.Wong, Eric ; Davis, Joanne E; Grigg, Andrew P ; Szer, Jeff; Ritchie, David
9Mar-2016Substantial variation in post-engraftment infection prophylaxis and revaccination practice in autologous stem cell transplant patientsLim, Hui Yin; Grigg, Andrew P 
102015Suspected acute hemolytic transfusion reaction mediated by anti-Di(a)Bennett, A ; Boyapati, RK; Hong, Frank S
11Jul-2021Systemic ALCL Treated in Routine Clinical Practice: Outcomes Following First-Line Chemotherapy from a Multicentre Cohort.Martinez-Calle, Nicolas; Kirkwood, Amy A; Lamb, Maxine; Smith, Alex; Khwaja, Jahanzaib; Manos, Kate ; Shrubsole, Caroline; Gray, Nicola; Lewis, Katharine; Tivey, Ann; Bishton, Mark J; Hawkes, Eliza A ; Ahearne, Matthew J; Osborne, Wendy; Collins, Graham P; Illidge, Timothy; Linton, Kim M; Cwynarski, Kate; Burton, Cathy; Fox, Christopher P
12Oct-2021T cell receptor beta locus sequencing early post-allogeneic stem cell transplant identifies patients at risk of initial and recurrent cytomegalovirus infection.Kuzich, James A; Kankanige, Yamuna; Guinto, Jerick; Ryland, Georgina; McBean, Michelle; Wong, Eric ; Koldej, Rachel; Collins, Jenny; Westerman, David; Ritchie, David; Blombery, Piers
13May-2023Targeting the BRAF pathway in haematological diseases.Rees, Matthew J ; Dickinson, Michael; Paterson, James; Ng, Teng F; Grigg, Andrew P ; Moore, John; Blombery, Piers; Seymour, John F
14Jul-2019The effect of tyrosine kinase inhibitor interruption and interferon use on pregnancy outcomes and long-term disease control in chronic myeloid leukemia.Lasica, Masa; Willcox, Abbey ; Burbury, Kate; Ross, David M; Branford, Susan; Butler, Jason; Filshie, Robin; Januszewicz, Henry; Joske, David; Mills, Anthony; Simpson, David; Tam, Constantine; Taylor, Kerry; Watson, Anne-Marie; Wolf, Max; Grigg, Andrew P 
1523-May-2017The incidence and natural history of dasatinib complications in the treatment of chronic myeloid leukemia.Fox, Lucy C; Cummins, Katherine D; Costello, Ben; Yeung, David; Cleary, Rebecca; Forsyth, Cecily; Tatarczuch, Maciek; Burbury, Kate; Motorna, Olga; Shortt, Jake; Fleming, Shaun; McQuillan, Andrew; Schwarer, Anthony P ; Harrup, Rosemary; Holmes, Amy; Ratnasingam, Sumita; Chan, Kah-Lok; Hsu, Wei-Hsun; Ashraf, Asma; Putt, Faye; Grigg, Andrew P
169-Apr-2019The natural history of vascular and other complications in patients treated with nilotinib for chronic myeloid leukemia.Minson, Adrian G; Cummins, Katherine; Fox, Lucy; Costello, Ben; Yeung, David; Cleary, Rebecca; Forsyth, Cecily; Tatarczuch, Maciek; Burbury, Kate; Motorna, Olga; Shortt, Jake; Fleming, Shaun; McQuillan, Andrew; Schwarer, Anthony; Harrup, Rosemary; Holmes, Amy; Ratnasingam, Sumita; Chan, Kah-Lok; Hsu, Wei-Hsun; Ashraf, Asma; Putt, Faye; Grigg, Andrew P 
17Dec-2018The pharmacokinetics and pharmacodynamics of busulfan when combined with melphalan as conditioning in adult autologous stem cell transplant recipients.Willcox, Abbey ; Wong, Eric ; Nath, Christa; Janson, Brett; Harrison, Simon J; Hoyt, Rosemary; Bajel, Ashish; Shaw, Peter; Ritchie, David; Grigg, Andrew P 
18Aug-2017The superficial femoral vein - time to change this misnomer.Chua, Chong Chyn ; Hong, Frank S; Ho, Wai Khoon 
191-May-2014Thrombopoietin receptor agonists in immune thrombocytopenia of less than 6 months duration.Arumugaswamy, A; He, S ; Quach, H; Brotchie, J; Grigg, Andrew P 
2017-Dec-2014TIDEL-II: first-line use of imatinib in CML with early switch to nilotinib for failure to achieve time-dependent molecular targets.Yeung, David T; Osborn, Michael P; White, Deborah L; Branford, Susan; Braley, Jodi A; Herschtal, Alan; Kornhauser, Michael; Issa, Samar; Hiwase, Devendra K; Hertzberg, Mark; Schwarer, Anthony P ; Filshie, Robin; Arthur, Christopher K; Kwan, Yiu Lam; Trotman, Judith; Forsyth, Cecily J; Taper, John; Ross, David M; Beresford, Jennifer; Tam, Constantine; Mills, Anthony K; Grigg, Andrew P ; Hughes, Timothy P